NCT03973333 2024-10-18
Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab
Immunocore Ltd
Phase 1/2 Withdrawn
Clinical Trials
8 trialsNCT06090318 2023-10-19
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Rain Oncology Inc
Phase 1/2 Withdrawn
NCT03427320 2022-07-11
Imaging of Advanced Tumours Using [131]I-IAZA
University of Alberta
Phase 1/2 Withdrawn
NCT05165849 2022-05-20
A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2 Withdrawn
NCT05177276 2022-01-04
Selinexor Combination Ph 1 Study
Hackensack Meridian Health
Phase 1/2 Withdrawn
NCT00668499 2014-05-21
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma
University of Southern California
Phase 1/2 Withdrawn
NCT01353482 2012-03-22
MESO-02
University College, London
Phase 1/2 Withdrawn
NCT00148993 2011-04-08
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
Hadassah Medical Organization
Phase 1/2 Withdrawn